Top

Journal of Endocrinological Investigation

Published in:

01-05-2021 | Premature Ejaculation | Consensus Statement

Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS)

Authors: A. Sansone, A. Aversa, G. Corona, A. D. Fisher, A. M. Isidori, S. La Vignera, E. Limoncin, M. Maggi, M. Merico, E. A. Jannini

Published in: Journal of Endocrinological Investigation | Issue 5/2021

Abstract

Premature ejaculation (PE) is the most prevalent male sexual dysfunction, and the most recently defined. PE is often mistakenly considered a purely psychosexological symptom by patients: the lacking awareness in regards to the pathophysiology and treatments often lead to resignation from the patients’ side, making PE the most underdiagnosed sexual complaint. However, an ever-growing body of evidence supporting several organic factors has been developed in the last decades and several definitions have been suggested to encompass all defining features of PE. In the present document by the Italian Society of Andrology and Sexual Medicine (SIAMS), we propose 33 recommendations concerning the definition, pathophysiology, treatment and management of PE aimed to improve patient care. These evidence-based clinical guidelines provide the necessary up-to-date guidance in the context of PE secondary to organic and psychosexological conditions, such as prostate inflammation, endocrine disorders, and other sexual dysfunctions, and suggest how to associate pharmacotherapies and cognitive-behavioral therapy in a couple-centered approach. New therapeutic options, as well as combination and off-label treatments, are also described.

Sansone A, Cignarelli A, Ciocca G, Pozza C, Giorgino F, Romanelli F, Jannini EA (2019) The sentiment analysis of tweets as a new tool to measure public perception of male erectile and ejaculatory dysfunctions. Sex Med 7(4):464–471. https://doi.org/10.1016/j.esxm.2019.07.001CrossRefPubMedPubMedCentral

Prieto-Castro R, Puigvert-Martinez AM, Artigas-Feliu R, Illan-Mateo P, Cruz-Culebra N, Artes-Ferragud M, Committee PPR (2020) Opinions, attitudes, and perceptions in relation to erectile dysfunction and premature ejaculation in the undiagnosed Spanish male population. Results of the PANDORA Project. J Sex Med 17(8):1495–1508. https://doi.org/10.1016/j.jsxm.2020.04.381CrossRefPubMed

Masters WH, Johnson VE (1970) Human sexual inadequacy. Churchill, London

Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93(3):666–673. https://doi.org/10.1210/jc.2007-1907CrossRefPubMed

Waldinger MD (2007) Four measures of investigating ejaculatory performance. J Sex Med 4(2):520. https://doi.org/10.1111/j.1743-6109.2007.00443_2.xCrossRefPubMed

Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G et al (2014) An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the definition of premature ejaculation. J Sex Med 11(6):1423–1441. https://doi.org/10.1111/jsm.12524CrossRefPubMed

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). American Psychiatric Association, WashingtonCrossRef

World Health Organization (2018) International classification of diseases 11th revision for mortality and morbidity statistics (ICD-11-MMS). World Health Organization, Geneva

Waldinger MD, Schweitzer DH (2019) Differences between ICD-11 MMS and DSM-5 definition of premature ejaculation: a continuation of historical inadequacies and a source of serious misinterpretation by some European Regulatory Agencies (PART 2). Int J Impot Res 31(5):310–318. https://doi.org/10.1038/s41443-018-0108-5CrossRefPubMed

10.

Waldinger MD (2003) Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res 15(5):309–313. https://doi.org/10.1038/sj.ijir.3901023CrossRefPubMed

11.

Giuliano F, Clement P (2006) Serotonin and premature ejaculation: from physiology to patient management. Eur Urol 50(3):454–466. https://doi.org/10.1016/j.eururo.2006.05.055CrossRefPubMed

12.

Chan JS, Snoeren EM, Cuppen E, Waldinger MD, Olivier B, Oosting RS (2011) The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats. J Sex Med 8(1):97–108. https://doi.org/10.1111/j.1743-6109.2010.01961.xCrossRefPubMed

13.

Janssen PK, Bakker SC, Rethelyi J, Zwinderman AH, Touw DJ, Olivier B, Waldinger MD (2009) Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med 6(1):276–284. https://doi.org/10.1111/j.1743-6109.2008.01033.xCrossRefPubMed

14.

Giuliano F, Rowland DL (2013) Standard operating procedures for neurophysiologic assessment of male sexual dysfunction. J Sex Med 10(5):1205–1211. https://doi.org/10.1111/jsm.12164CrossRefPubMed

15.

Jannini EA, Burri A, Jern P, Novelli G (2015) Genetics of human sexual behavior: where we are, where we are going. Sex Med Rev 3(2):65–77. https://doi.org/10.1002/smrj.46CrossRefPubMed

16.

Jern P, Ventus D (2018) Serotonergic polymorphisms in the control of ejaculation. Mol Cell Endocrinol 467:60–65. https://doi.org/10.1016/j.mce.2017.10.017CrossRefPubMed

17.

Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M (2012) The hormonal control of ejaculation. Nat Rev Urol 9(9):508–519. https://doi.org/10.1038/nrurol.2012.147CrossRefPubMed

18.

Culha MG, Tuken M, Gonultas S, Cakir OO, Serefoglu EC (2020) Frequency of etiological factors among patients with acquired premature ejaculation: prospective, observational, single-center study. Int J Impot Res 32(3):352–357. https://doi.org/10.1038/s41443-019-0188-xCrossRefPubMed

19.

Ozturk MI, Koca O, Tuken M, Keles MO, Ilktac A, Karaman MI (2012) Hormonal evaluation in premature ejaculation. Urol Int 88(4):454–458. https://doi.org/10.1159/000336137CrossRefPubMed

20.

Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH (2005) Thyroid-stimulating hormone assessments in a Dutch cohort of 620 men with lifelong premature ejaculation without erectile dysfunction. J Sex Med 2(6):865–870. https://doi.org/10.1111/j.1743-6109.2005.00142.xCrossRefPubMed

21.

Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA (2005) Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 90(12):6472–6479. https://doi.org/10.1210/jc.2005-1135CrossRefPubMed

22.

Cihan A, Demir O, Demir T, Aslan G, Comlekci A, Esen A (2009) The relationship between premature ejaculation and hyperthyroidism. J Urol 181(3):1273–1280. https://doi.org/10.1016/j.juro.2008.10.150CrossRefPubMed

23.

Gonen M, Kalkan M, Cenker A, Ozkardes H (2005) Prevalence of premature ejaculation in Turkish men with chronic pelvic pain syndrome. J Androl 26(5):601–603. https://doi.org/10.2164/jandrol.04159CrossRefPubMed

24.

Liang CZ, Zhang XJ, Hao ZY, Shi HQ, Wang KX (2004) Prevalence of sexual dysfunction in Chinese men with chronic prostatitis. BJU Int 93(4):568–570. https://doi.org/10.1111/j.1464-410x.2003.04662.xCrossRefPubMed

25.

Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA (2001) Prevalence of chronic prostatitis in men with premature ejaculation. Urology 58(2):198–202. https://doi.org/10.1016/s0090-4295(01)01151-7CrossRefPubMed

26.

Shamloul R, El-Nashaar A (2006) Chronic prostatitis in premature ejaculation: a cohort study in 153 men. J Sex Med 3(1):150–154. https://doi.org/10.1111/j.1743-6109.2005.00107.xCrossRefPubMed

27.

La Vignera S, Condorelli RA, Vicari E, Favilla V, Morgia G, Calogero AE (2016) Acquired premature ejaculation and male accessory gland infection: relevance of ultrasound examination. Asian J Androl 18(5):769–772. https://doi.org/10.4103/1008-682X.155539CrossRefPubMed

28.

La Vignera S, Condorelli R, Vicari E, D’Agata R, Calogero AE (2012) High frequency of sexual dysfunction in patients with male accessory gland infections. Andrologia 44(Suppl 1):438–446. https://doi.org/10.1111/j.1439-0272.2011.01202.xCrossRefPubMed

29.

Li HJ, Kang DY (2016) Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis. World J Urol 34(7):1009–1017. https://doi.org/10.1007/s00345-015-1720-3CrossRefPubMed

30.

El-Nashaar A, Shamloul R (2007) Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis. J Sex Med 4(2):491–496. https://doi.org/10.1111/j.1743-6109.2006.00243.xCrossRefPubMed

31.

Magri V, Montanari E, Skerk V, Markotic A, Marras E, Restelli A, Naber KG, Perletti G (2011) Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl 13(6):819–827. https://doi.org/10.1038/aja.2011.36CrossRefPubMedPubMedCentral

32.

Zohdy W (2009) Clinical parameters that predict successful outcome in men with premature ejaculation and inflammatory prostatitis. J Sex Med 6(11):3139–3146. https://doi.org/10.1111/j.1743-6109.2009.01487.xCrossRefPubMed

33.

Sansone A, Romanelli F, Jannini EA, Lenzi A (2015) Hormonal correlations of premature ejaculation. Endocrine 49(2):333–338. https://doi.org/10.1007/s12020-014-0520-7CrossRefPubMed

34.

McMahon CG, Jannini EA, Serefoglu EC, Hellstrom WJ (2016) The pathophysiology of acquired premature ejaculation. Transl Androl Urol 5(4):434–449. https://doi.org/10.21037/tau.2016.07.06CrossRefPubMedPubMedCentral

35.

Bellastella G, Maiorino MI, Olita L, Della Volpe E, Giugliano D, Esposito K (2015) Premature ejaculation is associated with glycemic control in Type 1 diabetes. J Sex Med 12(1):93–99. https://doi.org/10.1111/jsm.12755CrossRefPubMed

36.

Jannini EA, Lombardo F, Lenzi A (2005) Correlation between ejaculatory and erectile dysfunction. Int J Androl 28(Suppl 2):40–45. https://doi.org/10.1111/j.1365-2605.2005.00593.xCrossRefPubMed

37.

Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M (2015) Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. J Sex Med 12(12):2291–2300. https://doi.org/10.1111/jsm.13041CrossRefPubMed

38.

Kamnerdsiri WA, Rodriguez Martinez JE, Fox C, Weiss P (2018) Clinical correlation between erectile function and ejaculatory function in the Czech male population. PLoS ONE 13(7):e0199588. https://doi.org/10.1371/journal.pone.0199588CrossRefPubMedPubMedCentral

39.

Jannini EA, Lenzi A, Isidori A, Fabbri A (2006) Subclinical erectile dysfunction: proposal for a novel taxonomic category in sexual medicine. J Sex Med 3(5):787–794. https://doi.org/10.1111/j.1743-6109.2006.00287.xCrossRefPubMed

40.

Jannini EA, Ciocca G, Limoncin E, Mollaioli D, Di Sante S, Gianfrilli D, Lombardo F, Lenzi A (2015) Premature ejaculation: old story, new insights. Fertil Steril 104(5):1061–1073. https://doi.org/10.1016/j.fertnstert.2015.08.035CrossRefPubMed

41.

Jannini EA, Isidori AM, Aversa A, Lenzi A, Althof SE (2013) Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions. J Sex Med 10(10):2359–2369. https://doi.org/10.1111/jsm.12315CrossRefPubMed

42.

Colonnello E, Ciocca G, Limoncin E, Sansone A, Jannini EA (2020) Redefining a sexual medicine paradigm: subclinical pre-mature ejaculation as a new taxonomic entity. Nat Rev Urol (In press)

43.

Montague DK, Broderick GA, Dmochowski RR, Heaton JPW, Lue TF, Nehra A, Sharlip ID (2010) Pharmacologic Management of Premature Ejaculation (2010). https://www.auanet.org/guidelines/premature-ejaculation-(2004-reviewed-and-validity-confirmed-2010). Accessed 28 Jan 2020

44.

Salonia A, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioglu A et al. (2020) Sexual and Reproductive Health. EAU Guidelines Office. https://uroweb.org/guideline/sexual-and-reproductive-health/. Accessed 26 Mar 2020

45.

Jannini EA, McMahon C, Chen J, Aversa A, Perelman M (2011) The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med 8(8):2135–2143. https://doi.org/10.1111/j.1743-6109.2011.02401.xCrossRefPubMed

46.

Corona G, Rastrelli G, Ricca V, Jannini EA, Vignozzi L, Monami M et al (2013) Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction. J Sex Med 10(4):1074–1089. https://doi.org/10.1111/jsm.12043CrossRefPubMed

47.

Ciocca G, Limoncin E, Lingiardi V, Burri A, Jannini EA (2018) Response regarding existential issues in sexual medicine: the relation between death anxiety and hypersexuality. Sex Med Rev 6(2):335–336. https://doi.org/10.1016/j.sxmr.2018.02.002CrossRefPubMed

48.

Limoncin E, Tomassetti M, Gravina GL, Ciocca G, Carosa E, Di Sante S et al (2013) Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress. J Urol 189(5):1830–1835. https://doi.org/10.1016/j.juro.2012.11.007CrossRefPubMed

49.

Maseroli E, Fanni E, Mannucci E, Fambrini M, Jannini EA, Maggi M, Vignozzi L (2016) Which are the male factors associated with female sexual dysfunction (FSD)? Andrology 4(5):911–920. https://doi.org/10.1111/andr.12224CrossRefPubMed

50.

Limoncin E, Lotti F, Rossi M, Maseroli E, Gravina GL, Ciocca G et al (2016) The impact of premature ejaculation on the subjective perception of orgasmic intensity: validation and standardisation of the ‘Orgasmometer.’ Andrology 4(5):921–926. https://doi.org/10.1111/andr.12220CrossRefPubMed

51.

Mollaioli D, Di Sante S, Limoncin E, Ciocca G, Gravina GL, Maseroli E et al (2018) Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: the Orgasmometer-F. PLoS ONE 13(8):e0202076. https://doi.org/10.1371/journal.pone.0202076CrossRefPubMedPubMedCentral

52.

Ciocca G, Limoncin E, Mollaioli D, Gravina GL, Carosa E, Di Sante S et al (2015) SIAMS survey on sexological screening during the assisted reproductive technologies in Italy. J Endocrinol Invest 38(9):999–1005. https://doi.org/10.1007/s40618-015-0286-7CrossRefPubMed

53.

Lotti F, Maggi M (2018) Sexual dysfunction and male infertility. Nat Rev Urol 15(5):287–307. https://doi.org/10.1038/nrurol.2018.20CrossRefPubMed

54.

Lenzi A, Lombardo F, Salacone P, Gandini L, Jannini EA (2003) Stress, sexual dysfunctions, and male infertility. J Endocrinol Invest 26(3 Suppl):72–76PubMed

55.

Althof SE, McMahon CG, Waldinger MD, Serefoglu EC, Shindel AW, Adaikan PG et al (2014) An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med 11(6):1392–1422. https://doi.org/10.1111/jsm.12504CrossRefPubMed

56.

Serefoglu EC, Cimen HI, Ozdemir AT, Symonds T, Berktas M, Balbay MD (2009) Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejaculatory latency time. Int J Impot Res 21(2):139–144. https://doi.org/10.1038/ijir.2008.58CrossRefPubMed

57.

Rosen RC, McMahon CG, Niederberger C, Broderick GA, Jamieson C, Gagnon DD (2007) Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol 177(3):1059–1064. https://doi.org/10.1016/j.juro.2006.10.044 (discussion 1064)CrossRefPubMed

58.

Burgio G, Giammusso B, Calogero AE, Mollaioli D, Condorelli RA, Jannini EA, La Vignera S (2019) Evaluation of the mistakes in self-diagnosis of sexual dysfunctions in 11,000 male outpatients: a real-life study in an andrology clinic. J Clin Med. https://doi.org/10.3390/jcm8101679CrossRefPubMedPubMedCentral

59.

Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L (2006) Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med 3(3):465–475. https://doi.org/10.1111/j.1743-6109.2006.00239.xCrossRefPubMed

60.

Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M (2009) The premature ejaculation profile: validation of self-reported outcome measures for research and practice. BJU Int 103(3):358–364. https://doi.org/10.1111/j.1464-410X.2008.08041.xCrossRefPubMed

61.

Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, Abraham L, Crossland A, Morris M (2007) Development and validation of a premature ejaculation diagnostic tool. Eur Urol 52(2):565–573. https://doi.org/10.1016/j.eururo.2007.01.028CrossRefPubMed

62.

Corona G, Jannini EA, Maggi M (2006) Inventories for male and female sexual dysfunctions. Int J Impot Res 18(3):236–250. https://doi.org/10.1038/sj.ijir.3901410CrossRefPubMed

63.

Kempeneers P, Andrianne R, Cuddy M, Blairy S (2018) Sexual cognitions, trait anxiety, sexual anxiety, and distress in men with different subtypes of premature ejaculation and in their partners. J Sex Marital Ther 44(4):319–332. https://doi.org/10.1080/0092623X.2017.1405299CrossRefPubMed

64.

Jannini EA, McCabe MP, Salonia A, Montorsi F, Sachs BD (2010) Organic vs psychogenic? The Manichean diagnosis in sexual medicine. J Sex Med 7(5):1726–1733. https://doi.org/10.1111/j.1743-6109.2010.01824.xCrossRefPubMed

65.

Sansone A, Sansone M, Proietti M, Ciocca G, Lenzi A, Jannini EA, Romanelli F (2017) Relationship between use of videogames and sexual health in adult males. J Sex Med 14(7):898–903. https://doi.org/10.1016/j.jsxm.2017.05.001CrossRefPubMed

66.

Rowland DL, Kolba TN (2018) The burden of sexual problems: perceived effects on men’s and women’s sexual partners. J Sex Res 55(2):226–235. https://doi.org/10.1080/00224499.2017.1332153CrossRefPubMed

67.

Revicki D, Howard K, Hanlon J, Mannix S, Greene A, Rothman M (2008) Characterizing the burden of premature ejaculation from a patient and partner perspective: a multi-country qualitative analysis. Health Qual Life Outcomes 6:33. https://doi.org/10.1186/1477-7525-6-33CrossRefPubMedPubMedCentral

68.

Burri A, Giuliano F, McMahon C, Porst H (2014) Female partner’s perception of premature ejaculation and its impact on relationship breakups, relationship quality, and sexual satisfaction. J Sex Med 11(9):2243–2255. https://doi.org/10.1111/jsm.12551CrossRefPubMed

69.

Jannini EA, Porst H (2011) A practical approach to premature ejaculation. Introduction: the asynchronous couple. J Sex Med 8(Suppl 4):301–303. https://doi.org/10.1111/j.1743-6109.2011.02456.xCrossRefPubMed

70.

Shindel AW, Vittinghoff E, Breyer BN (2012) Erectile dysfunction and premature ejaculation in men who have sex with men. J Sex Med 9(2):576–584. https://doi.org/10.1111/j.1743-6109.2011.02585.xCrossRefPubMedPubMedCentral

71.

Limoncin E, Gravina GL, Lotti F, Maseroli E, Ciocca G, Corona G et al (2019) The Masturbation Erection Index (MEI): validation of a new psychometric tool, derived from the six-item version of the International Index of Erectile Function (IIEF-6) and from the Erection Hardness Score (EHS), for measuring erectile function during masturbation. BJU Int 123(3):530–537. https://doi.org/10.1111/bju.14560CrossRefPubMed

72.

Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF et al (2011) The comparison of premature ejaculation assessment questionnaires and their sensitivity for the four premature ejaculation syndromes: results from the Turkish society of andrology sexual health survey. J Sex Med 8(4):1177–1185. https://doi.org/10.1111/j.1743-6109.2010.02183.xCrossRefPubMed

73.

Jannini EA, Lenzi A, Wagner G (2006) Behavioural therapy and counselling. Androl Clinician. https://doi.org/10.1007/3-540-33713-x_100CrossRef

74.

Capogrosso P, Ventimiglia E, Oreggia D, Salonia A, Montorsi F (2017) Medical treatment of erectile dysfunction: too many medical prescriptions? Urologia 84(3):121–129. https://doi.org/10.5301/uj.5000250CrossRefPubMed

75.

Ciocca G, Limoncin E, Mollaioli D, Gravina GL, Di Sante S, Carosa E, Lenzi A, Jannini EA (2013) Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculation. Arab J Urol 11(3):305–312. https://doi.org/10.1016/j.aju.2013.04.011CrossRefPubMedPubMedCentral

76.

Pavone C, Abbadessa D, Gambino G, Scaduto G, Vella M (2017) Premature ejaculation: pharmacotherapy vs group psychotherapy alone or in combination. Arch Ital Urol Androl 89(2):114–119. https://doi.org/10.4081/aiua.2017.2.114CrossRefPubMed

77.

Jern P (2014) Evaluation of a behavioral treatment intervention for premature ejaculation using a handheld stimulating device. J Sex Marital Ther 40(5):358–366. https://doi.org/10.1080/0092623X.2013.857376CrossRefPubMed

78.

Jannini EA, Simonelli C, Lenzi A (2002) Sexological approach to ejaculatory dysfunction. Int J Androl 25(6):317–323. https://doi.org/10.1046/j.1365-2605.2002.00371.xCrossRefPubMed

79.

Melnik T, Althof S, Atallah AN, Puga ME, Glina S, Riera R (2011) Psychosocial interventions for premature ejaculation. Cochrane Database Syst Rev 8:CD008195. https://doi.org/10.1002/14651858.CD008195.pub2CrossRef

80.

Andersson KE, Mulhall JP, Wyllie MG (2006) Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for “on-demand” treatment of premature ejaculation. BJU Int 97(2):311–315. https://doi.org/10.1111/j.1464-410X.2006.05911.xCrossRefPubMed

81.

Giuliano F (2011) Neurophysiology of erection and ejaculation. J Sex Med 8(Suppl 4):310–315. https://doi.org/10.1111/j.1743-6109.2011.02450.xCrossRefPubMed

82.

Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, Miloslavsky M, Kell S, Dapoxetine Study G (2006) Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 368(9539):929–937. https://doi.org/10.1016/S0140-6736(06)69373-2CrossRefPubMed

83.

McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB, Aquilina JW et al (2011) Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med 8(2):524–539. https://doi.org/10.1111/j.1743-6109.2010.02097.xCrossRefPubMed

84.

Sridharan K, Sivaramakrishnan G, Sequeira RP, Al-Khaja KA (2018) Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials. Int J Impot Res 30(5):215–223. https://doi.org/10.1038/s41443-018-0030-xCrossRefPubMed

85.

Jian Z, Wei X, Ye D, Li H, Wang K (2018) Pharmacotherapy of premature ejaculation: a systematic review and network meta-analysis. Int Urol Nephrol 50(11):1939–1948. https://doi.org/10.1007/s11255-018-1984-9CrossRefPubMed

86.

Li J, Liu D, Wu J, Fan X, Dong Q (2018) Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized controlled trials with trial sequential analysis. Ann Saudi Med 38(5):366–375. https://doi.org/10.5144/0256-4947.2018.366CrossRefPubMedPubMedCentral

87.

Du Y, Jiang Y, Zhang J, Tian G, Zhang N, Wu D, Bai X (2019) Efficacy and safety of “on-demand” dapoxetine in treatment of patients with premature ejaculation: a meta-analysis. Med Sci Monit 25:4225–4232. https://doi.org/10.12659/MSM.913606CrossRefPubMedPubMedCentral

88.

Zhao GJ, Guo Q, Li YF, Zhang YG (2019) Efficacy and safety of dapoxetine for premature ejaculation: an updated systematic review and meta-analysis. Sex Health 16(4):301–313. https://doi.org/10.1071/SH18005CrossRefPubMed

89.

Hutchinson K, Cruickshank K, Wylie K (2012) A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation. Drug Saf 35(5):359–372. https://doi.org/10.2165/11598150-000000000-00000CrossRefPubMed

90.

Atmaca M (2020) Selective serotonin reuptake inhibitor-induced sexual dysfunction: current management perspectives. Neuropsychiatr Dis Treat 16:1043–1050. https://doi.org/10.2147/NDT.S185757CrossRefPubMedPubMedCentral

91.

Porst H, Burri A (2019) Novel treatment for premature ejaculation in the light of currently used therapies: a review. Sex Med Rev 7(1):129–140. https://doi.org/10.1016/j.sxmr.2018.05.001CrossRefPubMed

92.

Carson C, Wyllie M (2010) Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study. J Sex Med 7(9):3179–3189. https://doi.org/10.1111/j.1743-6109.2010.01913.xCrossRefPubMed

93.

Dinsmore WW, Wyllie MG (2009) PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int 103(7):940–949. https://doi.org/10.1111/j.1464-410X.2009.08456.xCrossRefPubMed

94.

Mirone V, Arcaniolo D, Rivas D, Bull S, Aquilina JW, Verze P, team Ps, (2014) Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. Eur Urol 65(4):733–739. https://doi.org/10.1016/j.eururo.2013.08.018CrossRefPubMed

95.

Mondaini N, Fusco F, Cai T, Benemei S, Mirone V, Bartoletti R (2013) Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a “Waterloo.” Urology 82(3):620–624. https://doi.org/10.1016/j.urology.2013.05.018CrossRefPubMed

96.

Park HJ, Park NC, Kim TN, Baek SR, Lee KM, Choe S (2017) Discontinuation of dapoxetine treatment in patients with premature ejaculation: a 2-year prospective observational study. Sex Med 5(2):e99–e105. https://doi.org/10.1016/j.esxm.2017.02.003CrossRefPubMedPubMedCentral

97.

Hou G, Gao M, Zhang L, Dun X, Zheng Y, Wang F et al (2020) Nomogram for predicting the possibility of improvement of the clinical global impression in patients with lifelong premature ejaculation treated with dapoxetine. J Sex Med (In press)

98.

Abdel-Hamid IA, Jannini EA, Andersson KE (2009) Premature ejaculation: focus on therapeutic targets. Expert Opin Ther Targets 13(2):175–193. https://doi.org/10.1517/14728220802663549CrossRefPubMed

99.

McMahon CG (2016) Emerging and investigational drugs for premature ejaculation. Transl Androl Urol 5(4):487–501. https://doi.org/10.21037/tau.2016.04.02CrossRefPubMedPubMedCentral

100.

Aversa A, Francomano D, Bruzziches R, Natali M, Spera G, Lenzi A (2011) Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation? Int J Impot Res 23(1):17–23. https://doi.org/10.1038/ijir.2010.34CrossRefPubMed

101.

Francomano D, Donini LM, Lenzi A, Aversa A (2013) Peripheral arterial tonometry to measure the effects of vardenafil on sympathetic tone in men with lifelong premature ejaculation. Int J Endocrinol 2013:394934. https://doi.org/10.1155/2013/394934CrossRefPubMedPubMedCentral

102.

Martyn-St James M, Cooper K, Ren K, Kaltenthaler E, Dickinson K, Cantrell A, Wylie K, Frodsham L, Hood C (2016) Topical anaesthetics for premature ejaculation: a systematic review and meta-analysis. Sex Health 13(2):114–123. https://doi.org/10.1071/SH15042CrossRefPubMed

103.

Zhang D, Cheng Y, Wu K, Ma Q, Jiang J, Yan Z (2019) Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. BMC Urol 19(1):2. https://doi.org/10.1186/s12894-018-0431-7CrossRefPubMedPubMedCentral

104.

Zhang X, Gao J, Liu J, Xia L, Yang J, Hao Z, Zhou J, Liang C (2013) Prevalence rate and risk factors of depression in outpatients with premature ejaculation. Biomed Res Int 2013:317468. https://doi.org/10.1155/2013/317468CrossRefPubMedPubMedCentral

105.

Waldinger MD (2018) Drug treatment options for premature ejaculation. Expert Opin Pharmacother 19(10):1077–1085. https://doi.org/10.1080/14656566.2018.1494725CrossRefPubMed

106.

Reisman Y (2017) Sexual consequences of post-SSRI syndrome. Sex Med Rev 5(4):429–433. https://doi.org/10.1016/j.sxmr.2017.05.002CrossRefPubMed

107.

Healy D, Le Noury J, Mangin D (2019) Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals. Int J Risk Saf Med 30(3):167–178. https://doi.org/10.3233/JRS-191005CrossRefPubMed

108.

Bala A, Nguyen HMT, Hellstrom WJG (2018) Post-SSRI sexual dysfunction: a literature review. Sex Med Rev 6(1):29–34. https://doi.org/10.1016/j.sxmr.2017.07.002CrossRefPubMed

109.

Aversa A, Pili M, Francomano D, Bruzziches R, Spera E, La Pera G, Spera G (2009) Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res 21(4):221–227. https://doi.org/10.1038/ijir.2009.21CrossRefPubMed

110.

Jannini EA, Lenzi A (2011) Sexual dysfunction: is acupuncture a therapeutic option for premature ejaculation? Nat Rev Urol 8(5):235–236. https://doi.org/10.1038/nrurol.2011.54CrossRefPubMed

111.

Ma GC, Zou ZJ, Lai YF, Zhang X, Zhang Y (2019) Regular penis-root masturbation, a novel behavioral therapy in the treatment of primary premature ejaculation. Asian J Androl 21(6):631–634. https://doi.org/10.4103/aja.aja_34_19CrossRefPubMedPubMedCentral

112.

Ahmed TA, Alay AMS, Okbazghi SZ, Alhakamy NA (2020) Two-step optimization to develop a transdermal film loaded with dapoxetine nanoparticles: a promising technique to improve drug skin permeation. Dose Response 18(2):1559325820923859. https://doi.org/10.1177/1559325820923859CrossRefPubMedPubMedCentral

113.

Althof S, Osterloh IH, Muirhead GJ, George K, Girard N, Group PM-CS (2019) The oxytocin antagonist cligosiban fails to prolong intravaginal ejaculatory latency in men with lifelong premature ejaculation: results of a randomized, double-blind, placebo-controlled phase IIb trial (PEDRIX). J Sex Med 16(8):1188–1198. https://doi.org/10.1016/j.jsxm.2019.05.015CrossRefPubMed

114.

Gallo L, Perdona S, Gallo A (2010) The role of short frenulum and the effects of frenulectomy on premature ejaculation. J Sex Med 7(3):1269–1276. https://doi.org/10.1111/j.1743-6109.2009.01661.xCrossRefPubMed

115.

Jannini EA (2010) Words of wisdom. Re: the role of short frenulum and the effects of frenulectomy on premature ejaculation. Eur Urol 57(6):1119–1120. https://doi.org/10.1016/j.eururo.2010.03.027CrossRefPubMed

116.

Anaissie J, Yafi FA, Hellstrom WJ (2016) Surgery is not indicated for the treatment of premature ejaculation. Transl Androl Urol 5(4):607–612. https://doi.org/10.21037/tau.2016.03.10CrossRefPubMedPubMedCentral

Title: Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS)
Authors: A. Sansone
A. Aversa
G. Corona
A. D. Fisher
A. M. Isidori
S. La Vignera
E. Limoncin
M. Maggi
M. Merico
E. A. Jannini
Publication date: 01-05-2021
Publisher: Springer International Publishing
Keywords: Premature Ejaculation
Premature Ejaculation
Erectile Dysfunction
Hyperthyroidism
Published in: Journal of Endocrinological Investigation / Issue 5/2021
Electronic ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-020-01458-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2021

Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a National Referral Center and review of the literature

Familial non-medullary thyroid cancer: a critical review

The cytokine storm and thyroid hormone changes in COVID-19

Anosmia and ageusia: a piece of the puzzle in the etiology of COVID-19-related transitory erectile dysfunction

The role of placental iodine storage in the neonatal thyroid stimulating hormone surge: iodine as a driving force to adapt the terrestrial life

Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials